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OBJECTIVE — Toanalyzetheeffectofdiabetesongeneralandcardiovasculardisease(CVD)
mortality and morbidity in southern Brazil.
RESEARCH DESIGN AND METHODS — A population-based cohort study of 1,091
individuals was conducted. Diabetes was ascertained by medical history. The vital status of 982
individuals and the incidence of events were ascertained during another visit and through
hospital records, death certiﬁcates, and verbal necropsy with relatives.
RESULTS — The mean  SD age of participants was 43.1  17 years, and 55.7% were
women. The prevalence of diabetes was 4.2%, and the mean follow-up time was 5.3  0.07
years. Mortality was 36.3% and 6.6% in participants with or without diabetes, respectively; the
incidence of CVD was 20.8% and 3.0%, with an adjusted hazard ratio of 4.4 (95% CI 2.4–7.9).
Diabetic population-attributable risk (PAR) for CVD mortality was 10.1% and 13.1% for total
CVD.
CONCLUSIONS — Diabetes is responsible for a large PAR for overall mortality and cardio-
vascular events in Brazil.
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A
pproximately 2.2 million deaths
worldwidefromischemicheartdis-
ease and stroke were attributed to
high levels of blood glucose in 2001 (1).
We describe the effect of diabetes on car-
diovascular disease (CVD) morbidity and
mortality in southern Brazil.
RESEARCH DESIGN AND
METHODS— The baseline data of
this cohort study were collected from
1989 and have previously been described
in detail 1991 (2,3). In brief, 1,091 par-
ticipants aged 18 years, identiﬁed
through a population-based multistage
probabilitysampling,wereinterviewedat
home after they had given informed con-
sent. Diabetes was established for partic-
ipants who self-reported a physician
diagnosis or who were using drugs for
diabetes.
Incident CVD was adjudicated if a
participant reported the occurrence of a
cardiovascular event since the baseline
visit, and a detailed history was obtained
or the cause of death was identiﬁed
through medical records and verbal nec-
ropsy with relatives. The ﬁnal ascertain-
ment of the cause of death and incident
CVD(myocardialinfarction,stroke,heart
failure, and sudden death) was done by
twocliniciansbasedoninterviewrecords,
death certiﬁcates, and hospital records.
Data were analyzed using the com-
plex sample module in SPSS (version 16).
Hazardratios(HRs)werecomputedusing
the survival analysis and the time frame
frombaselinetothesecondvisitastimeto
event, adjusting for age, sex, skin color,
smoking habits, alcohol consumption,
blood pressure, and BMI. Diabetic popu-
lation-attributable risk (PAR), adjusted
for the same confounders, was computed
with the Interactive Risk Assessment Pro-
gram (version 2.2; National Cancer Insti-
tute, Bethesda, MD).
RESULTS— The mean  SD age of
the 982 individuals was 43.1  17 years
(range 18–81), and 55.7% were women.
Overall prevalence of diabetes was 4.2%
(95% CI 3.0–5.8) and increased to 7.3%
(5.4–10.0) among participants aged 40
years, as only three individuals aged 40
years reported diabetes. The mean fol-
low-up time was 5.3  1.5 years, being
5.4  1.5 years for nondiabetic individu-
als and 4.1  2.1 years for diabetic indi-
viduals (P  0.001). Participants who
reported diabetes were older (62.8 
14.7 vs. 55.5  16.7 years; P  0.001)
and had higher BMI (28.4  4.9 vs.
26.2  4.6 kg/m
2; P  0.001) and sys-
tolic blood pressure (149.2  26.9 vs.
135.222.2mmHg;P0.001).Table1
shows that the medical diagnosis of dia-
betes was a strong risk factor for overall
mortality and fatal plus nonfatal CVD
events. In the analysis stratiﬁed by skin
color, the HRs were signiﬁcant for white
participants for overall mortality (4.2
[95% CI 2.1–8.4]), fatal CVD events (2.0
[1.1–3.6]), and fatal plus nonfatal CVD
events(5.0[2.4–10.0]).Innonwhitepar-
ticipants, the estimates remained at the
risksidebutweresigniﬁcantonlyforfatal
plus nonfatal CVD events: 2.8 (95% CI
0.7–11.3) for overall mortality, 1.1 (0.3–
3.4) for fatal CVD events, and 5.5 (1.2–
24.7) for fatal plus nonfatal CVD events.
Diabetes explained about 9% of over-
all mortality, 10% of CVD mortality, and
13% of fatal plus nonfatal cardiovascular
events in this population, with an ad-
justed PAR of 9.8 (95% CI 3.8–22.9),
10.1 (1.9–39.2), and 13.1 (5.8–26.9),
respectively.
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based cohort study conﬁrmed that diabe-
tes is a major risk factor for overall
mortality and fatal and nonfatal cardio-
vascular events in southern Brazil, dem-
onstrating that Brazilian populations had
already experienced the epidemiological
transition and are presenting with risks
forchronicdiseasessimilartothoseinde-
veloped countries. The risks were not
substantially different in white and non-
white individuals.
The baseline prevalence of diabetes
(4.2%) was somewhat lower than that re-
ported in another recent survey in Brazil
(6.3%)(4)andintheNationalHealthand
Nutrition Examination Surveys (NHAN-
ESs) of 1988–1994 (5.1%) and 1999–
2002 (6.5%) (5) and may be secondary to
an underreporting.
Overall mortality incidence in dia-
betic participants accounted for 19.2% of
the deaths, which is more than the 10.6%
reported in NHANES I (6). The high in-
cidence of cerebrovascular disease in the
southernregionsofBrazil(7)mayexplain
this higher prevalence because diabetes
has been associated with increased risk of
incidentstroke(8,9).Therisksforcardio-
vascular events were almost restricted to
individuals aged 40 years because only
three individuals reported diabetes at a
younger age.
TheadjustedHRforfatalandnonfatal
CVD in our study (4.4 [95% CI 2.4–7.9])
is similar to the odds ratio of 4.2 (95% CI
2.5–7.1) for acute myocardial infarction
reported in the INTERHEART study in
Brazil(10).ThePARoffatal/nonfatalCVD
associated with self-reported diabetes
(13.1%) is close to the 12.7% (9.4–17.0)
reportedinSouthAmericaandtothedata
reported in the Brazilian participants of
the INTERHEART study (17.0% [95% CI
12.2–23.1]) (11).
The major limitation of our study is
the small sample size and, therefore, the
small number of incident events. This ex-
plains the wide CIs and precluded strati-
ﬁcation of the analysis by sex. Other
studies (11–13) suggested that the risk of
fatalornonfatalcoronaryheartdiseaseas-
sociatedwithdiabetesishigherinwomen
than in men. Otherwise, a cohort of Bra-
ziliantype2diabeticpatients(14)didnot
demonstrate any differences in diabetes-
related mortality risk between sexes. The
diagnosis of diabetes—based on medical
history without screening by blood glu-
cose sampling—may explain the lower
prevalence of diabetes in our study than
in other Brazilian surveys (15), but it
probably did not substantially inﬂuence
the risk estimates as shown by Huxley et
al. (13). The PAR, however, is inﬂuenced
by the prevalence rates and therefore may
be higher than our estimates. The popu-
lation-based sample and the control for
other risk factors for CVD are strengths of
our study.
In conclusion, diabetes has a high
PARforcardiovasculareventsinBrazil.As
such,interventionsaimingtopreventand
control diabetes should warrant high pri-
orityamongthepublichealthstrategiesto
lower the incidence of CVD in Brazil.
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